StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
ADMA Biologics
5.72
+3.62%
 

ADMA

 

ADMA Biologics

$ 5.72

 
+$0.20 | +3.62%
 
 
Open
$ 5.59
 
 
MKT CAP
$ 1.31B
 
High
$ 5.81
 
 
VOL
$ 2.56M
 
Low
$ 5.52
 
 
AVG VOL
$ 2.33M
 
 
 

ADMA Stock Analysis

  Login to display ADMA Biologics (ADMA) recommendation from the last 90 days from financial news and social media.
 
 

ADMA Total Score

 
 

Risk Analysis

ADMA Risk Analysis

 Earnings are forecast to decrease

 
 

Chart

 
 

5.29

3.82

3.16

3.28

 
 
1month
3month
6month
1year
 
Total Return
ADMA
vs.
S&P500
 

 
1-week Return
+3.62%
 
+1.04%
 
 
5-week Return
+12.38%
 
+4.91%
 
 
10-week Return
+35.55%
 
+7.60%
 
 
 

ADMA Risk Level

This Indicator assigning ADMA risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
ADMA Risk Level
LOW
HIGH

Risk Volatility

 

ADMA has Low Risk Level

Click here to check what is your level of risk

 

ADMA Analysts Opinion

ADMA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.33
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

3.17
 

ADMA Future Sentiment

 Earnings are forecast to decrease

 
 

ADMA Analysts Opinion

ADMA Analysts opinion is negative and it remained unchanged from the past 3 months

 

ADMA Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
73%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
67%
67%
 
On Track
On Track
On Track
 

ADMA Street Opinion 

ADMA Street view is bullish and have positive views on the near-term outlook

 

ADMA Performance Sentiment

Sentiments overview associated with ADMA events and the stock performance.
 
73%
27%
Positive
Negative
11 out of 15
events present
4 out of 15
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

ADMA Earnings

The TTM reflects 12-month period, providing review of ADMA financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
234
154
81
+69.97%
 
 
Cost of Revenue
162
119
80
+42.30%
 
 
Gross Profit
72
35
1
+748.53%
 
 
Operating Exp
71
75
60
+8.78%
 
 
Operating Inc
1
-39
-58
-
 
 
Net Interest Inc
-24
-19
-13
-
 
 
Interest Exp
25
19
13
+38.68%
 
 
Interest Inc
1
-
 
 
Other Income
-1
-7
-
 
 
EPS
-0.11
-0.33
-0.51
-
 
 
Next Earnings Date: Mar 06, 2024
 
 
Highlights
Last Modify
Price
% Change

 
Strong Earnings
This Week
5.38
-2.54%
 
Agreements
1 Week Ago
5.18
+0.58%
 
 
 
joker
 
 
 
StocksRunner

Explore our ADMA Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ADMA Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 
 

Stock Insights

 
 
 
 

Risk Analysis

 

ADMA Risk Analysis

 Earnings are forecast to decrease

 
 
 

ADMA Risk Level

 
 
 

The Indicator assigning ADMA risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
ADMA Risk Level
LOW
HIGH

Risk Volatility

 

ADMA has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

ADMA

 

ADMA Biologics

$ 5.72

 
+$0.20 | +3.62%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 5.59
 
 
MKT CAP
$ 1.31B
 
High
$ 5.81
 
 
VOL
$ 2.56M
 
Low
$ 5.52
 
 
AVG VOL
$ 2.33M
 
 
 

ADMA Analysis

  Sign in to view ADMA Biologics (ADMA) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

5.29

3.82

3.16

3.28

 
 
1month
3month
6month
1year
 
Total Return
ADMA
vs.
S&P500
 

 
1-week Return
+3.62%
 
+1.04%
 
 
5-week Return
+12.38%
 
+4.91%
 
 
10-week Return
+35.55%
 
+7.60%
 
 
 

ADMA Analysts Opinion

ADMA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.33
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

3.17
 

ADMA Future Sentiment

 Earnings are forecast to decrease

 
 

ADMA Analysts Opinion

ADMA Analysts opinion is negative and it remained unchanged from the past 3 months

 

ADMA Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
73%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
67%
67%
 
On Track
On Track
On Track
 

ADMA Street Opinion 

ADMA Street view is bullish and have positive views on the near-term outlook

 
ADMA Performance Sentiment
Sentiments overview associated with ADMA events and the stock performance.
 
73%
27%
Positive
Negative
11 out of 15
events present
4 out of 15
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

ADMA Earnings

The TTM data reflects the most recent 12-month period, providing overview of ADMA financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
234
154
81
+69.97%
 
 
Cost of Revenue
162
119
80
+42.30%
 
 
Gross Profit
72
35
1
+748.53%
 
 
Operating Exp
71
75
60
+8.78%
 
 
Operating Inc
1
-39
-58
-
 
 
Net Interest Inc
-24
-19
-13
-
 
 
Interest Exp
25
19
13
+38.68%
 
 
Interest Inc
1
-
 
 
Other Income
-1
-7
-
 
 
EPS
-0.11
-0.33
-0.51
-
 
 
Next Earnings Date: Mar 06, 2024
 
Highlights
Last Modify
Price
% Change

 
Strong Earnings
This Week
5.38
-2.54%
 
Agreements
1 Week Ago
5.18
+0.58%
 
 
ADMA Latest News Feed

Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Heres is How to Trade. Shares of Adma Biologics (ADMA) have gained 1.1% over the past four weeks to close the last trading session at $5.36 but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts ar

Fri Mar 1, 2024

Potential
Potential

Forecasting The Future: 4 Analyst Projections For ADMA Biologics. Analysts'. ratings for ADMA Biologics (NASDAQ:) over the last quarter vary from ish to bearish as provided by 4 analysts. The following table provides a quick overview of their recent

Thu Feb 29, 2024

Momentum
Potential

ADMA Biologics GAAP EPS of -$0.08 misses by $0.11 revenue of $73.9M beats by $0.93M.

Wed Feb 28, 2024

Earnings
Earnings

ADMA Biologics CFO to step down.

Wed Feb 28, 2024

Activity

ADMA Biologics Successfully Implements Innovative AI Program Named ADMAlytics. ADMA Successfully Utilized ADMAlytics'. New Capabilities for the First Time to Automate and Realize Efficiency Improvements for Commercial Production Plasma Pooling Broader

Wed Feb 21, 2024

Activity

adma biologics (adma) stock declines while market improves: some information for investors. adma biologics (adma) ended the recent trading session at $5.18 demonstrating a -1.71% swing from the

Wed Feb 7, 2024

Activity
Momentum

cracking the code: understanding analyst reviews for adma biologics. in the latest quarter 4 analysts provided ratings for adma biologics (nasdaq:) showcasing a mix of ish and bearish perspectives. the following table provides a quick overview of their r

Mon Jan 22, 2024

Potential

brokers suggest investing in adma biologics (adma): read this before placing a bet. when deciding whether to buy sell or hold a stock investors often rely on analyst recommendations. media repo

Wed Jan 17, 2024

Potential

adma biologics provides q4 and fy guidance. shares rise.

Mon Jan 8, 2024

Momentum

adma biologics announces preliminary fourth quarter 2023 revenue and provides business update. fy 2024 and 2025 total revenue guidance increased to more than $320 million and $370 million respectively fy 2024 net income expected to exceed $60 million and

Mon Jan 8, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 15 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 19:04 Wall St. time
 
 

ADMA Total Score

 
 
 
 
 
 
 
StocksRunner

Discover ADMA Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of ADMA. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ADMA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ADMA Stock trends

ADMA Stock performance

ADMA Stock analysis

ADMA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker